Discover all our publications
Web3 and Scientific Research, Interview with Kamil Ramdani – Nosty
Continuing our exploration of Decentralized Science, the ResolvingPharma team is delighted to bring you an exclusive interview with Kamil Ramdani, co-founder of Nosty. This cutting-edge platform leverages Web3 tools to…
Introduction to DeSci
How Science of the Future is being born before our eyes « [DeSci] transformed my research impact from a low-impact virology article every other year to saving the lives and…
Interview with Christophe Baron, Founder of Louis App: “NFTs to promote disease prevention and longevity”
Questions asked by Alexandre Demailly We thank Mr Christophe Baron for his time and answers and wish Louis App a long life! To discover the app: https://www.louisapp.io/ 1] Could you…
Artificial intelligence against bacterial infections: the case of bacteriophages
« If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine…
Towards virtual clinical trials?
Clinical trials are among the most critical and expensive steps in drug development. They are highly regulated by the various international health agencies, and for good reason: the molecule or…
Interview – Molecule, the start-up that wants to revolutionise the financing of drug development with the Blockchain
The Resolving Pharma team is pleased to inaugurate a series of interviews with start-ups creating the pharmaceutical world of tomorrow with this interview with Molecule, a young and ambitious German…
Reshaping real-world data sharing with Blockchain-based system
“[Blockchain] is a complicated technology and one whose full potential is not necessarily understood by healthcare players. We want to demonstrate […] precisely that blockchain works when you work on…
3D printing and artificial intelligence: the future of galenics?
“Ten years from now, no patient will take the same thing as another million people. And no doctor will prescribe the same thing to two patients.” Fred Paretti from the…
Why are we still conducting meta-analyses by hand?
« It is necessary, while formulating the problems of which in our further advance we are to find solutions, to call into council the views of those of our predecessors…
Oligonucleotides and Machine Learning Tools
Today, oligonucleotides – short DNA or RNA molecules – are essential tools in molecular biology projects, but also in therapeutics and diagnostics. In 2021, ten or so antisense therapies are…
Health data: an introduction to the synthetic data revolution
Data, sometimes considered as the black gold of the 21st century, are the essential fuel for artificial intelligence and are already widely used by the pharmaceutical industry. However, and especially…
Blockchain, Mobile Apps: will technology solve the problem of counterfeit drugs?
« Fighting counterfeit drugs is only the start of what blockchain could achieve through creating [pharmaceutical] ‘digital trust’.» Andreas Schindler, Blockchain Expert 20% of the medicines circulating in the world are…
Using Real World Data, an interview with Elise Bordet – RWD and Analytics Lead
Every month, Resolving Pharma interviews the stakeholders who shape the health and pharmaceutical industries of tomorrow. In this first interview, Elise Bordet honors us with her participation, many thanks for…
Robots in the lab: will tomorrow’s researchers also be roboticists?
Frequently, there are very repetitive and laborious tasks in a laboratory that could be automated. Whether it’s compiling data on a spreadsheet or preparing a gel for electrophoresis, the ratio…
Organ-On-Chip: Towards totally miniaturized assays?
Before testing a new molecule in Humans, it is necessary to make toxicological and pharmacokinetic predictions with various preclinical models. Researchers try to reconstruct as best as they can what…
Dismantling the scientific publishers’ cartel to free innovation ?
” Text mining of academic papers is close to impossible right now. “ Max Häussler – Bioinformatics researcher, UCSC Faced with the explosion of published scientific articles and the exponential…
Eroom’s Law, the pharmaceutical industry of tomorrow and Resolving Pharma
372. It is the number of days between the discovery of the first Covid-19 case in Wuhan, and the vaccination of Margaret Keenan in central England, the first person to…
Contact : hello@resolving-pharma.com Join us on LinkedIn